DELIVERY OF AN OCULAR AGENT
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jun 20, 2006
filing date -
Sep 26, 2005
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method to ameliorate inflammatory effects by providing an anti-platelet derived growth factor (anti-PDGF) agent. In one embodiment the agent is imatinib. In another embodiment the agent is dasatinib. The method reduces the undesirable effects of post-surgical scarring, such as restenosis, because of the anti-inflammatory effect of the anti-PDGF agent. The method may be used in patients undergoing any type of surgery, such as cardiac surgery, ocular surgery, vascular surgery, etc.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully